SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-16-014641
Filing Date
2016-03-14
Accepted
2016-03-14 06:31:38
Documents
84
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nerv-10k_20151231.htm 10-K 2074376
2 EX-21.1 nerv-ex211_9.htm EX-21.1 4423
3 EX-23.1 nerv-ex231_6.htm EX-23.1 2211
4 EX-31.1 nerv-ex311_11.htm EX-31.1 16592
5 EX-31.2 nerv-ex312_7.htm EX-31.2 16557
6 EX-32.1 nerv-ex321_10.htm EX-32.1 7342
7 GRAPHIC g2016031118581273911287.jpg GRAPHIC 37462
  Complete submission text file 0001564590-16-014641.txt   7208009

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nerv-20151231.xml EX-101.INS 1223822
9 XBRL TAXONOMY EXTENSION SCHEMA nerv-20151231.xsd EX-101.SCH 61342
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20151231_cal.xml EX-101.CAL 57806
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20151231_def.xml EX-101.DEF 242607
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20151231_lab.xml EX-101.LAB 472079
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20151231_pre.xml EX-101.PRE 411356
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36517 | Film No.: 161502363
SIC: 2834 Pharmaceutical Preparations